1. Home
  2. MYO

as 07-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Industrial Specialties

Nasdaq

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Founded: N/A Country:
United States
United States
Employees: N/A City: BOSTON
Market Cap: 92.5M IPO Year: 2017
Target Price: $7.00 AVG Volume (30 days): 791.0K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.27 EPS Growth: N/A
52 Week Low/High: $0.50 - $5.58 Next Earning Date: 08-07-2024
Revenue: $19,548,839 Revenue Growth: 29.17%
Revenue Growth (this year): 41.37% Revenue Growth (next year): 38.01%

MYO Daily Stock ML Predictions

Stock Insider Trading Activity of Myomo Inc. (MYO)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
KIRK THOMAS F MYO Director May 29 '24 Buy $3.50 50,000 $175,000.00 236,499 SEC Form 4
Kovelman Harry MYO Chief Medical Officer May 15 '24 Sell $3.69 35,426 $130,838.85 98,009 SEC Form 4
KIRK THOMAS F MYO Director Mar 14 '24 Buy $3.50 50,000 $175,000.00 186,499 SEC Form 4
KIRK THOMAS F MYO Director Nov 20 '23 Buy $3.10 50,000 $155,000.00 136,499 SEC Form 4

Share on Social Networks: